Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  by Kawada, Hiroshi et al.
See related Commentary on page v
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1
and Reduced Function of its Promoter in Hailey–Hailey Disease
Keratinocytes
Hiroshi Kawada,w Chiharu Nishiyama,w Atsushi Takagi,w Tomoko Tokura, Nobuhiro Nakano,
Keiko Maeda, Nobuyasu Mayuzumi,w Shigaku Ikeda,w Ko Okumura, and Hideoki Ogawaw
Atopy (Allergy) Research Center and wDepartment of Dermatology, Juntendo University School of Medicine, Tokyo, Japan
Hailey–Hailey disease (HHD) is a blistering skin disease caused by malfunction of the Ca2þ -dependent ATPase,
ATP2C1. In this study, key regulatory regions necessary for the expression of the gene encoding human ATP2C1
were investigated. The transient reporter assay demonstrated that region þ 21/þ 57 was necessary for activation of
the ATP2C1 promoter, and the electrophoretic mobility shift assay demonstrated that the region was recognized by
the transcription factors, Sp1 and YY1. In accordance with this result, when Sp1 or YY1 was overexpressed in
keratinocytes, an obvious increase in ATP2C1 promoter activity was observed, which was in contrast with the case
where a mutant promoter lacking the binding sites for Sp1 and YY1 was used as the reporter. Ca2þ -stimulation
signal increased nuclear Sp1 proteins and ATP2C1 mRNA levels in normal keratinocytes. In contrast, both these
increases were suppressed in keratinocytes from HHD patients. These results indicate that Sp1 and YY1 trans-
activate the human ATP2C1 promoter via cis-enhancing elements and that incomplete upregulation of ATP2C1
transcription contributes to the keratinocyte-specific pathogenesis of HHD. This is a report describing the reg-
ulation of the expression of ATP2C1.
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Hailey–Hailey disease (HHD) is an autosomal dominant blis-
tering skin disease that is histologically characterized by
defects in cell-to-cell adhesion in the suprabasal layers of
the epidermis (acantholysis). HHD results from mutations in
a Ca2þ ATPase, ATP2C1 (Hu et al, 2000; Sudbrak et al,
2000). ATP2C1 is a Ca2þ ATPase localized to the Golgi
apparatus and pumps Ca2þ from the cytosol to the Golgi
apparatus. In normal keratinocytes, elevated extracellular
Ca2þ concentration causes differentiation of the cells and
induction of differentiated keratinocyte-specific gene ex-
pressions. In HHD keratinocytes, however, the cytoplasmic
Ca2þ response to stimulation caused by increase of extra-
cellular Ca2þ concentration is suppressed because of
a decrease in ATP2C1 activity. These data suggest that
decreased function of ATP2C1 in HHD keratinocytes may
account for the suppression of differentiated keratinocyte-
specific gene expression that is essential for cell-to-cell
adhesion. Recently, Behne et al (2003) reported that the
decreased expression of ATP2C1 protein in keratinocytes
was a probable cause of HHD. This observation suggests
that specific control of ATP2C1 expression would give us
useful information to restore the decreased function of AT-
P2C1 in HHD keratinocytes.
Although ATP2C1 is a critical molecule for HHD, there
has been no report on the mechanism for transcriptional
regulation of ATP2C1 gene. In this report, we describe the
analysis of transcriptional regulatory elements for the
human ATP2C1 gene expression by using the luciferase
reporter assay and electrophoretic mobility shift assay
(EMSA), and demonstrate that transcription factors Sp1
and YY1 transactivate ATP2C1 gene expression by recog-
nizing the cis-enhancing elements in 50-untranslated (50-UT)
region in keratinocyte cells. We also found that Ca2þ -in-
duced upregulation of both Sp1 protein level in the nucleus
and ATP2C1 transcription were markedly suppressed in
HHD keratinocytes.
Results
Determination of transcription start site of the human
ATP2C1 gene To determine the transcription start site of
the human ATP2C1 gene, we performed 50-rapid amplifi-
cation of cDNA end (50-RACE) using total RNA from AT-
P2C1-positive keratinocyte cell line HaCaT, and found that
DNA fragments showing four distinct bands in agarose gel
electrophoresis were amplified (Fig 1A). The nucleotide se-
quence of each DNA fragment, which was subcloned onto a
plasmid vector, was determined by sequencing analysis. A
band of approximately 200 bp contained the sequence
corresponding to the 50-flanking region of ATP2C1 gene,
whereas the other three bands (shown with asterisks in
Abbreviations: EMSA, electrophoretic mobility shift assay; HHD,
Hailey–Hailey disease; NHK, normal human keratinocyte; 50-RACE,
50-rapid amplification of cDNA end; 50-UT, 50-untranslated
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
1206
Fig 1A) were identified to be DNA fragments of non-related
genes (data not shown). The transcription start site of the
human ATP2C1 gene was determined (Fig 1B) according to
the 50-terminus of each clone.
Analysis of the transcriptional regulatory region of the
ATP2C1 gene To identify the regulatory elements required
for the expression of the human ATP2C1 gene, a series of
deletion constructs were generated in which various lengths
of the 50-upstream region of the ATP2C1 gene were con-
nected to the upstream portion of the luciferase gene.
Luciferase activity was then measured in HaCaT cells that
were transfected with these reporter plasmids. The longest
region (347/þ76) showed apparent promoter activity in
comparison with the basic control (Fig 1C). But a 37 bp
deletion of its 50-terminus to yield 310/þ76 caused a
marked decrease in promoter activity, whereas a 217 bp
deletion (see 93/þ76) did not cause a significant de-
crease in the activity. These results suggest that the region
from 347 to 311 contains cis-enhancing element(s). Fur-
thermore, deletion of the region from þ22 to þ76 resulted
in the marked reduction of the promoter activity to levels
nearly equal to that of the promoter-less construct. These
observations indicate that the positive cis-acting element(s)
critical for the promoter activity is/are present in the 50-UT
region of the human ATP2C1 gene.
The above-mentioned deletion analysis suggested that
there were two enhancing regions (347/311 and þ22/
þ 76) involved in the expression of the ATP2C1 gene. In this
study, we analyzed the function of the latter region for the
expression of the ATP2C1 gene. Analysis of the upstream
region possibly containing elements to enhance the promoter
activity will be performed in the near future and will be de-
scribed elsewhere. We generated a series of reporter plasm-
ids carrying the ATP2C1 gene in which nucleotide substi-
tution of 4–5 bp was introduced into þ 21/þ 64 of pGL-AT-
P2C1 (347/þ76) (Fig 2). The mutated promoters, M2–7,
showed drastically decreased activity, compared with other
promoters. This indicates that the elements essential for the
promoter function are present in the region from þ 21 to þ 57.
Sp1 and YY1 bind to cis-enhancing elements of the AT-
P2C1 gene EMSA was performed using nuclear extracts
from HaCaT cells, to identify nuclear proteins binding to the
above-mentioned essential elements of 50-UT. When a 50-
FITC-labeled double-stranded oligonucleotide of þ 21/þ 44
Figure 1
Determination of the transcriptional
regulatory region of the human ATP2C1
promoter. (A) Agarose gel electrophoresis
of 50-rapid amplification of cDNA end (50-
RACE) products. Bands shown with an
asterisk are PCR products of non-related
genes. (B) 50-end of ATP2C1 mRNA de-
termined by 50-RACE analysis. (C) Activity
of the human ATP2C1 promoter deter-
mined by luciferase assay. Nucleotide
numbers are shown where the transcrip-
tional start site determined by 50-RACE is
expressed as þ1. Deletion constructs of
the human ATP2C1 promoter were tran-
siently introduced into HaCaT cells. The
luciferase (Luc) activity is given relative to
that of pGL3-Bacis (promoterless plasm-
id), and the results are expressed as the
mean  SE of more than three independ-
ent experiments.
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(probe 1) was used as a probe, several shift bands were
observed (Fig 3A). Motif analysis using the program,
TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.
html), revealed the presence of recognition motifs for var-
ious transcription factors, including Sp1, YY1, NF-kB, and
the Ets family, in this region. To confirm the binding of these
transcription factors to þ21/þ44 of the ATP2C1 gene,
EMSA was performed in the presence of anti-Sp1, -YY1,
-NF-kB, -Elf-1, or -Elk-1 antibody (Fig 3A). When anti-Sp1
antibody was added in a protein–DNA mixture, the most
slowly migrating band was diminished but a super shift
band appeared (Fig 3A). EMSA in the presence of anti-YY1
antibody also resulted in the disappearance of a shift band
(Fig 3A, lane 4), whereas addition of other antibodies did not
affect the EMSA profile. These results indicate that Sp1 and
YY1 bind to þ21/þ44 of the ATP2C1 gene. To confirm that
Sp1 and YY1 bound to this region, EMSA was performed
with recombinant Sp1 and YY1 prepared by an in vitro tran-
scription/translation system. As shown in Fig 3B, the specific
shift band showing mobility identical to that seen with the
nuclear protein was generated when recombinant Sp1 was
used. Furthermore, disappearance of this specific band and
simultaneous appearance of a supershift band were ob-
served in the presence of anti-Sp1 antibody as seen in the
case in which nuclear proteins were used. When an in vitro
transcription/translation reaction mixture including YY1
cDNA as a template was added, a specific shift band show-
ing mobility identical to that of the band seen in EMSA using
nuclear extract appeared (Fig 3C). Furthermore, this band
disappeared in the presence of anti-YY1 antibody (Fig 3C).
For further identification of the recognition sequence of
Sp1, we performed competition assays by using 50- or 100-
fold excess amounts of unlabeled wild-type or mutant-type
double-stranded oligonucleotide. The most slowly migrating
band disappeared when the mixture was incubated in the
presence of WT, competitor 1, 5, or 6 (Fig 4B). In contrast,
addition of competitor 2, 3, or 4 was less effective when
used to compete with the labeled probe (Fig 4B). These
Figure2
Determination of cis-enhancing
elements in the 50-untranslated
region of the human ATP2C1 gene
by site-directed mutagenesis. Mu-
tations were introduced into þ21/
þ 64 of the reporter plasmid carry-
ing the human ATP2C1 promoter
(347/þ 76). Various mutant plasm-
ids were introduced into HaCaT
cells. Nucleotides that differed from
the original sequences are shown,
and lines represent unchanged nuc-
leotides in mutant plasmids. Results
are expressed as the mean  SE of
more than three independent exper-
iments. WT, wild type; M1–8, mutant
1–8.
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results indicate that GGGGAACTCCTT (þ 25/þ 36) serves
as a core sequence for the binding of Sp1. Similarly, the
YY1-binding site was identified as CCTTCCTCAGCC (þ37/
þ44; data not shown).
Sp1 and YY1 transactivate the ATP2C1 promoter To elu-
cidate the transactivating role of Sp1 and YY1 in ATP2C1
promoter function, the effect of overexpression of Sp1 or YY1
on the ATP2C1 promoter activity was assessed by co-expres-
sion study in normal human keratinocyte (NHK) cells. When the
NHK cells were co-transfected with Sp1- or YY1-expression
plasmid, a significantly higher amount of Sp1 or YY1 was
overproduced in these cells (Fig 5A). The ATP2C1 promoter
(347/þ76) was upregulated 3- and 2-fold by exogenously
expressed Sp1 and YY1, respectively (Fig 5B). In contrast,
exogenous Sp1 and YY1 produced no significant effect when
the mutant promoter lacking recognition motifs of Sp1 and
YY1 (347/þ 21) or when basic control was used (Fig 5B).
These results suggest that Sp1 and YY1 transactivate the AT-
P2C1 promoter via binding motifs in 50-UT in keratinocytes.
Effect of Ca2þ on transcription level of ATP2C1 and
nuclear accumulation of Sp1 Ca2þ stimulation induces
nuclear localization of Sp1 and a terminal differentiation
program of keratinocytes similar to that observed in the
upper epidermal layers, including induction of differentia-
tion-related genes (Santini et al, 2001). Therefore, we analy-
zed the effect of Ca2þ -stimulation on ATP2C1 transcription
and the amount of nuclear Sp1 and YY1. To examine tran-
scription levels of ATP2C1 in keratinocytes, we performed a
semi-quantitative PCR using total RNA prepared from un-
differentiated (cultured in 0.06 mM Ca2þ ) NHK and differ-
entiated (cultured in 1.2 mM Ca2þ ) NHK, and found that
mRNA for ATP2C1 was markedly increased (Fig 6B). As
expected, Ca2þ stimulation induced the accumulation of
Sp1 proteins in the nucleus (Fig 6A). On the other hand,
Ca2þ stimulation was Sp1 specific, because the amount of
nuclear YY1 was not affected by the stimulation (Fig 6A).
These results suggest that Ca2þ stimulation induces the
accumulation of Sp1 in the nucleus, and the accumulated
transcription factor promotes the transcription of ATP2C1.
Nuclear Sp1 level and ATP2C1 transcription level in
keratinocytes from HHD patients HHD keratinocytes
show a decrease in cytoplasmic Ca2þ response to stimu-
lation with raised extracellular Ca2þ because of the de-
creased function of ATP2C1 that controls Golgi Ca2þ stores
(Hu et al, 2000; Behne et al, 2003). This suggested the
possibility that transcription of genes that should be upreg-
ulated in differentiated keratinocytes might be abnormal in
HHD keratinocytes. We hypothesized that ATP2C1 tran-
script may be decreased in differentiated keratinocytes
from HHD patients. To explore this possibility, we compared
nuclear Sp1 proteins levels and ATP2C1 transcription levels
between undifferentiated and differentiated keratinocytes
from HHD patients and controls. When relative Sp1 protein
levels were calculated based on the intensity of bands de-
tected in western blotting with nuclear extract by using an
irrelevant USF2 protein, in which the amount in the nucleus
is not affected by Ca2þ stimulation, as a control (Fig 7A),
Sp1 proteins in the nucleus of control keratinocytes were
upregulated in response to Ca2þ stimulation as well as that
Figure 3
Identification of nuclear proteins binding to the 50-untranslated region of the human ATP2C1 gene by electrophoretic mobility shift assay
(EMSA). (A) EMSA was performed with FITC-labeled probe 1 and nuclear extract from HaCaTcells. Lane 1, probe only; lanes 2–7, probe with nuclear
extract. Added antibody is shown above each lane. (B) Mobility profile of recombinant Sp1. Lanes 2 and 3, with nuclear extract; lanes 4 and 5, with
recombinant Sp1; lanes 1, 2, and 4, without anti-Sp1 antibody; lanes 3 and 5, with anti-Sp1 antibody. (C) Mobility profile of in vitro-translated YY1.
Lanes 2 and 3, with nuclear extract; lanes 4 and 5, with in vitro translated YY1; lanes 6 and 7, with in vitro transcription/translation mixture without
template cDNA; lanes 1, 2, 4, and 6, without anti-YY1 antibody; lanes 3, 5, and 7, with anti-YY1 antibody.
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of NHK, whereas this upregulation was suppressed in ker-
atinocytes from HHD patients (Fig 7B). When ATP2C1 mRNA
levels were analyzed by real-time PCR, ATP2C1 mRNA levels
were dramatically increased in differentiated control keratin-
ocytes and NHK. Ca2þ stimulation did not affect, however,
ATP2C1 mRNA levels in keratinocytes from HHD patients
(Fig 7C). These results demonstrate that expression of AT-
P2C1 mRNA was upregulated in normal differentiated kera-
tinocytes but not in differentiated HHD keratinocytes.
Discussion
The human ATP2C1 gene has been identified to be an
HHD-related gene, because the mutation of ATP2C1 caus-
es this disease (Hu et al, 2000; Sudbrak et al, 2000). Re-
cently, it was reported that protein levels of ATP2C1 were
decreased in keratinocytes from HHD patients and that ab-
normal Ca2þ signaling was seen in HHD keratinocytes (Be-
hne et al, 2003). Therefore, information on the mechanism of
gene expression might be useful for further understanding
the cause of HHD and for development of a new therapeutic
method for the disease. There has been no report, however,
analyzing the mechanism for ATP2C1 gene expression. In
this study, we analyzed the promoter structure of the human
ATP2C1 gene and found the 50-UT region containing the
critical cis-enhancing elements by using the transient re-
porter assay. In addition, transcription factors Sp1 and YY1
were identified to bind to the elements by EMSA. We also
showed that these transcription factors transactivated the
ATP2C1 promoter via the cis-enhancing elements in kera-
tinocyte cells. Furthermore, we found that upregulation of
ATP2C1 transcription caused by Ca2þ -stimulation signal
was markedly suppressed in HHD keratinocytes, probably
because of reduced upregulation of nuclear Sp1 protein.
The ATP2C1 gene is transcribed at a high level in human
epidermal keratinocytes, although transcription of ATP2C1
was also observed in other human tissues at moderate lev-
els (Hu et al, 2000). Both Sp1 and YY1 are expressed in
various cell types. Therefore, it would be reasonable to think
that these transcription factors might be involved in the ex-
pression of ATP2C1 in a cell-type-independent manner. In
other instances, however, Sp1 and YY1 have been reported
to be involved in the transcriptional regulation of the ker-
atinocyte-specific genes related to terminal differentiation of
keratinocytes, such as loricrin (Jang and Steinert, 2002),
transglutaminase 3 (Lee et al, 1996), and involucrin (Lopez-
Bayghen et al, 1996). Considering that relatively high levels
of Sp1 expression are observed in keratinocytes (Saffer
et al, 1991), keratinocyte-specific gene expression mediat-
ed by Sp1 may be controlled by the expression level of Sp1.
It is also possible to postulate that another keratinocyte-
specific transcription factor or cofactor might be involved in
the expression of keratinocyte-specific genes in a cooper-
ative manner with Sp1 and YY1.
By EMSA with competitive oligonucleotides, Sp1 was
identified to bind to the region þ 25/þ 36 (Fig 4). In the
region that bound to Sp1, no complete canonical Sp1-
binding sequence, 50-(G/T)GGGCGG(G/A)(G/A)(C/T)-30
(Thiesen and Bach, 1990; Nagaoka et al, 2002), was found.
We assumed firstly that a palindromic sequence,
GGAACTCC (þ27/þ34), which is similar to the 30-half of
the Sp1-consensus sequence, could serve as the Sp1-
binding site in the human ATP2C1 gene. When we per-
formed co-expression analysis using a mutant reporter
plasmid with nuclear replacements at þ 29/þ 33 (M3 in
Fig 2), however, promoter activity was still upregulated by
exogenous Sp1 (data not shown). This result suggests the
presence of other Sp1-binding sequences in this region.
The TGGGCGGGG (þ 20/þ 28) sequence is also similar to
the optimal consensus-binding sequence of Sp1. Therefore,
the sequence may be an alternative candidate for the Sp1-
binding site. As for the YY1-binding site, the CAG sequence
of þ 40/þ 42 might serve as a core motif, considering that
NC(A/C)(T/G)NNN was shown to be recognizable by YY1
(Shrivastava and Calame, 1994). Luciferase activity directed
by a mutant reporter plasmid with replacement at þ41/
þ 45, however, was increased by co-expression of YY1.
Considering that the YY1-binding sequence is relatively
flexible, the complicated result may be explained by the
presence of other YY1-bindable sequences in this area. Al-
ternatively, the close proximity of Sp1- and YY1-binding
sites might make the effect of each transcription factor
more complex. Further detailed analysis will be required to
reveal the cooperative mechanism between Sp1 and YY1
and to clarify the involvement of YY1. Nonetheless, this
study suggests that Sp1 and YY1 transactivated the human
Figure 4
Determination of binding sites of transcription factor Sp1. Lane 1,
probe only; lanes 2–16, with nuclear extract; lanes 3–4, 5–6, 7–8, 9–10,
11–12, 13–14, and 15–16, with competitor WT, C1, C2, C3, C4, C5, and
C6, respectively. The amount of competitor was 50-fold excess in lanes
3, 5, 7, 9, 11, 13, and 15, and 100-fold excess in lanes 4, 6, 8, 10, 12,
14, and 16.
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ATP2C1 promoter via binding sequences located between
þ22/þ76.
As shown in Fig 1C, deletion of the 347/311 region
caused an apparent decrease in the transcription activity of
the promoter. Further, nucleotide replacement in 50-UT
caused a marked decrease in the promoter activity (Fig 2),
and mutated promoter M8 showed slightly decreased ac-
tivity in comparison with that of the wild type one. These
results suggest that other transcription factors or cofactors
might be involved in the regulation of ATP2C1 gene ex-
pression. With regard to the latter region, when we per-
formed EMSA by using þ41/þ60 as a probe (probe 2), did
not detect a specific band shift (data not shown). Additional
detailed analysis of these regions would be of benefit in
further clarifying these regulatory mechanisms.
The region within the 50-UT was essential for the pro-
moter function of the human ATP2C1. Although a regulatory
element for the gene expression is often found within its
own promoter or upstream of the promoter, there are in-
creasing number of instances in which the 50-UT contains a
regulatory element (Yamamoto et al, 1999; Morii et al, 2001;
Akizawa et al, 2003). Sp1 also binds to the 50-UT of the
insulin-like growth factor I receptor gene (Beitner-Johnson
et al, 1995). Further study on the ATP2C1 promoter may be
of benefit to characterize the functional and structural dif-
ferences between the typical promoter and the 50-UT-de-
pendent promoter.
It is known that ATP2C1 function is decreased in HHD
keratinocytes. In this study, we have shown that upregula-
tion of ATP2C1 expression, which is induced by Ca2þ -
stimulation signal for cell differentiation in normal keratin-
ocytes, was not observed in HHD keratinocytes. Therefore,
it is reasonable to think that the difference in ATP2C1 func-
tion may become larger after differentiation between normal
keratinocytes and HHD keratinocytes. We may assume that
it is a possible reason why HHD is usually found in the upper
layer of the epidermis where keratinocytes are in the final
stage of differentiation. In previous reports, low protein lev-
els were observed in ATP2C1 mutants, which were over-
produced in COS-1 cells by transiently introduced
Figure 5
Transcription activation of the ATP2C1
promoter by Sp1 and YY1. (A) Western blot-
ting analysis of transfectants. To examine
protein levels of transcription factors, 1/5
volumes of whole transfected cell lysate in
each well of six-well plate were subjected to
western blot analysis. (B) Two micrograms of
reporter plasmids were introduced with 100
ng pCR3.1 (mock), pCR-Sp1, or pCR-YY1
into normal human keratinocytes. The relative
promoter activity is represented as the ratio
to the luciferase activity in the cells trans-
fected with pGL3-Basic and mock vector.
Typical results obtained with triplicate sam-
ples are shown and similar results were ob-
tained with other independent experiments.
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plasmids, whereas transcription levels of ATP2C1 mutants
were comparable (Fairclough et al, 2003, 2004). The re-
duced protein levels were suggested to be probably be-
cause of a rapid rate of mutant protein degradation.
Considering this, the stability of mutant proteins might be
critical for the expression level of ATP2C1 proteins. There-
fore, there is a possibility that the level of ATP2C1 mutant
proteins was further decreased in HHD keratinocytes by
both the effect of suppressed transcription and enhanced
degradation. Since we did not analyze the protein levels of
ATP2C1 in this study, further analysis will be required to
clarify this possibility. In this study, Ca2þ stimulation was
used to induce development of keratinocytes. Since Ca2þ
signaling itself is defective in Hailey–Hailey keratinocytes,
there is a possibility that suppression of ATP2C1 promoter
in HHD keratinocytes was enhanced by the deficient func-
tion of ATP2C1. In vivo analysis of transcription and trans-
lation level of ATP2C1 in keratinocytes of HHD is required
for further clarification of the involvement of ATP2C1 pro-
moter in the pathogenesis of HHD.
Materials and Methods
Cell culture HaCaT cells were cultured in DMEM (Sigma-Aldrich,
St Louis, Missouri) supplemented with 10% FBS (Sigma-Aldrich),
100 U per mL penicillin, and 100 mg per mL streptomycin. NHK,
derived from normal newborn foreskin, were purchased from
KURABO (Osaka, Japan) and maintained in a serum-free standard
medium Epilife-KGM (KURABO) containing 0.06 mM Ca2þ , 10 mg
per mL insulin, 0.1 ng per mL hEGF, 0.5 mg per mL hydrocortisone,
50 mg per mL gentamicin, 50 ng per mL amphotericin-B, and 0.4%
BPE. Second-to-fourth-passage keratinocytes that were 60%–
90% confluent in a monolayer were used for experiments. We used
HaCaT cells in a reporter assay and EMSA to identify transcription
factors essential for ATP2C1 gene regulation after confirmation that
HaCaT is an ATP2C1-positive cell line, because cell lines generally
express a higher amount of transcription factors compared with
primary cells and are used for identification of cis-elements and
trans-activators. NHK were used to evaluate the effect of ex-
ogenous transcription factors by co-expression analysis, because
the amount of endogenous target transcription factors in NHK was
confirmed to be lower than that of HaCaT. NHK were also used to
analyze levels of transcription factor proteins in nucleus and AT-
P2C1 transcription in response to Ca2þ stimulation, because NHK
is a primary keratinocyte that differentiates in response to an in-
crease of extracellular Ca2þ concentration.
Selection of HHD patients and controls HHD individuals were
patients of Juntendo University Hospital, who were diagnosed be-
fore entry into the study, demonstrating the typical clinical findings
and histopathology, i.e., blistering and erosions in characteristic
locations, and acantholysis of suprabasal cells without apoptosis.
Keratinocytes from HHD patients and healthy control were gener-
ated from a skin biopsy of the trunk and were used for experiments
in their second-to-fourth passages. HHD patient #1 in this study
was described in a previous report (Ikeda et al, 2001) as JHHD-10
with an in-frame deletion in ATP2C1 gene, 2215delATT, causing
deletion of Ile at 739th.
The Ethics Committee of Juntendo University School of Med-
icine approved this study. This study was conducted according to
the Declaration of Helsinki Principles and participants gave their
written informed consent.
RT-PCR and 50-RACE Total RNA was prepared from HaCaT cells
using TRIzol reagent (Invitrogen, Leek, the Netherlands). A 50-
RACE kit (Invitrogen) was used for 50-RACE analysis. The following
oligonucleotides were used as primers for 50-RACE: GSP1 (50-
CGAAACTGCACTCGGGTTGATGGCTACAAA-30), GSP2 (50-AA-
TAGAGAGGAGAGGAGGAGGACAAGGAG-30), and GSP3 (50-CA-
CCCCTAGCAGCAGCATCTGCAAGAGAAA-30). Each PCR product
was subcloned into pCR2.1 by using a TOPO TA cloning kit (In-
vitrogen), and nucleotide sequences were determined by an ABI
PRISM377 DNA sequencer (Applied Biosystems, Foster City,
California).
Plasmid construction The 50-flanking region (approximately 450
bp) including a 50-UT region of human ATP2C1 gene was prepared
by PCR using 50-cagatctGCCCTCTCTCCCTCCCTTCCT-30 and
50-caagcttAAGAGAAACCAGGAGAAGCGGCGCTGACGA-30 (re-
placed nucleotides for introduction of BglII and HindIII sites (in
italics) are shown as small letters) as the primers and the human
genomic DNA prepared from peripheral blood by a DNA quick kit
(Dainippon Pharmaceutical, Osaka, Japan) as the template. The
amplified genomic DNA fragment were inserted into the BglII–
HindIII site of pGL3-Basic (Promega, Madison, Wisconsin) after
digestion with restriction endonucleases, BglII and HindIII (Takara
BIO, Otsu, Japan). The nucleotide sequences of inserted DNA
fragment was confirmed by sequencing analysis. Other plasmids
containing a variety of 50- or 30-truncation of the ATP2C1 promoter
region connected to the upstream region of the luciferase gene
were constructed in a similar manner using a QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, California) and
Figure 6
Effect of Ca2þ-stimulation signal on the amount of nuclear tran-
scription factors and transcription level of ATP2C1 in normal hu-
man keratinocyte (NHK). (A) The amount of Sp1 and YY1 proteins in
nucleus of NHK and HaCaT cells. Five micrograms of nuclear extract
was applied onto each lane and analyzed by western blotting. Lane 1,
nuclear extract from NHK cells cultured in the presence of 0.06 mM
Ca2þ ; lane 2, nuclear extract from NHK cells stimulated with 1.2 mM
Ca2þ for 24 h; lane 3, nuclear extract from HaCaT cells. (B) Semi-
quantitative PCR to analyze the transcription level of ATP2C1. PCR
products obtained after 25 (lanes 1 and 4), 28 (lanes 2 and 5), and 31
(lanes 3 and 6) cycles were applied onto agarose gel and detected by
ethidium bromide staining. One microgram total RNA from non-stim-
ulated NHK (lanes 1–3) and from stimulated NHK (lanes 4–6) were used
as the template for RT.
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restriction endonucleases. All of the constructs in which 4–5 bp
were replaced with others were produced by site-directed muta-
genesis. The expression plasmid, pCR-YY1 (Nishiyama et al, 2002,
2003), was used for in vitro transcription/translation of YY1 and co-
expression analysis. The plasmid pCR-Sp1 for expression of Sp1
in keratinocytes was generated by cloning the coding region of
Sp1 cDNA (accession number; BC062539), which was amplified
from total RNA prepared from NHK by RT-PCR using 50-
CTGCCACCATGAGCGACCAAGATCACTCCA-30 (the translational
initiation codon is shown in bold) and 50-CCGGGTGCCTGATCTCA
GAAGCCATTGCCA-30 (the termination codon is shown in bold) as
primers, into pCR-3.1 (Invitrogen) in the appropriate orientation.
Transfection and luciferase assay HaCaT cells (1  105) were
transfected with 2 mg reporter plasmid, and 25 ng pRL-CMV
(Promega), which was used as the internal control of transfection
efficiency, by Fugene6 (Roche Diagnostics, Indianapolis, Indiana)
according to the manufacturer’s instruction. For co-expression
analysis, NHK (1  105) were transfected with 2 mg reporter plasm-
id, and 25 ng pRL-null (Promega) with 100 ng expression plasmid,
pCR-3.1 (mock), pCR-Sp1, or pCR-YY1. After 20–24 h of culture,
luciferase activity of each whole-cell lysate was measured using a
Dual-luciferase assay kit (Promega) and a luminescence detector,
Micro Lumat Plus (Berthold, Postfach, Germany) as described
previously (Akizawa et al, 2003; Maeda et al, 2003).
EMSA Probes for EMSA were prepared by annealing 50-FITC-
labeled synthesized oligonucleotides of complementary sequenc-
es. The sequences of sense strand of probe were: probe-1,
50-GGGCGGGGAACTCCTTCCTCAGCC-30 and probe-2, 50-
AGCCTCTCGTCAGCGCCGCT-30 (Invitrogen). The non-labeled
double-stranded oligonucleotides (see Fig 4A) were prepared in a
similar manner and used as a competitor. Nuclear extracts from
HaCaT cells were prepared as previously described (Nishiyama
et al, 1999; Maeda et al, 2003). Recombinant Sp1 protein was
purchased from ProteinOne.com (College Park, Maryland). In vitro
transcription and translation of YY1 was performed with a TNT T7
Quick coupled transcription/translation system (Promega) using
pCR-YY1 as the template. Five picomole probes were mixed with
the nuclear extract of 5 mg of protein, 1.2 mg of recombinant Sp1, or
1 mL of in vitro transcription/translation mixture containing YY1
protein. This mixture was applied onto a 4% polyacrylamide gel.
One microgram of each antibody, anti-Sp1, anti-YY1, anti-NFkB
p65, anti-Elf-1, and anti-Elk-1 (Santa Cruz Biotechnology, Santa
Figure 7
Levels of nuclear Sp1 proteins and ATP2C1
mRNA in keratinocytes from Hailey–Hailey
disease (HHD) patients. (A) Western blotting
analysis of Sp1 (top) and USF2 (bottom) proteins
in the nucleus of keratinocytes from normal and
HHD individuals. Control 1, commercially ob-
tained normal human keratinocytes; Control 2,
normal human keratinocytes from volunteer;
HHD, keratinocytes from HHD patient. The num-
bers of ‘‘Control’’ and ‘‘HHD’’ indicate the corre-
sponding individuals in (A–C). (B) The relative
Sp1 protein levels in the nucleus. Densitometric
analysis was used to assess the relative Sp1
protein levels normalized to the irrelevant nuclear
protein, USF2. The scale of Y-axis on the left is
for control 1 and HHD 3, and the scale on the
right is for other cells. (C) Quantification of AT-
P2C1 mRNA levels in control and HHD keratin-
ocytes by real-time PCR. The expression level of
the ATP2C1 (ATP2C1/GAPDH) of each individual
is represented as the ratio to that of non-stim-
ulated normal human keratinocyte.
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Cruz, California) was added into the protein–probe mixture to
identify the nuclear proteins binding to the probe–DNA. Compe-
tition assay was performed as described previously (Hasegawa
et al, 2003). Gels were subjected to a fluorescence detector, Flu-
oroImager 595 (Molecular Dynamics, Sunnyvale, California).
Western blotting analysis Whole cell or nuclear extracts pre-
pared by the method described above were subjected to western
blotting analysis. The amount of subjected samples is described in
each figure legend. Western blotting analysis was performed as
described previously (Ito et al, 2005). In brief, anti-Sp1, anti-YY1
antibodies that were used in EMSA as described above, and anti-
USF2 antibody (Santa Cruz Biotechnology) were used as the pri-
mary antibodies. Alexa Fluor 800 goat anti-mouse IgG, Alexa Fluor
680 goat anti-mouse IgG, or Alexa Fluor 680 goat anti-rabbit IgG
(Molecular Probes) were used as secondary antibodies to detect
Sp1, YY1, and USF2, respectively. Infrared fluorescence on mem-
branes was detected by the Odyssey infrared imaging system
(model ODY-9201-SC; LI-COR, Lincoln, Nebraska).
Quantiﬁcation of ATP2C1 mRNA Total RNA was prepared from
NHK cells as described above. Reverse transcription was per-
formed using a ThermoScript First-Strand Synthesis System for
RT-PCR (Invitrogen). The Advantage 2 polymerase mix (BD Clon-
tech, Palo Alto, California) was used for semi-quantitative PCR with
the following primer set: 50-TGACAGGTGAGACAACGCCTTGTTC-
30, and 50-TCACTGTGACCACAATGGGGAGAC-30 to detect AT-
P2C1 expression, and a primer set to detect GAPDH expression
was purchased from BD Clontech. PCR products after an appro-
priate number of cycles were subjected to agarose gel elect-
rophoresis. The amount of ATP2C1 mRNA was also quanti-
fied using a 7500 Real-Time PCR System (Applied Biosystems)
with an Assays-on-Demand gene expression product (no.
Hs00205122_m1 for human ATP2C1) and TaqMan Universal PCR
Master Mix (Applied Biosystems). The expression level of ATP2C1
was normalized to that of GAPDH as described previously (Nishi-
yama et al, 2004). The ATP2C1 expression level in Fig 7C is shown
as the ratio to that of non-stimulated NHK according to the fol-
lowing equations:
The ATP2C1 mRNA expression level ¼ 2ðCt sampleÞðCt controlÞ
Ct sample ¼ ðCt value of ATP2C1 of each sampleÞ
 ðCt value of GAPDH of each sampleÞ
Ct control ¼ ðCt value of ATP2C1 of non-stimulated NHKÞ
 ðCt value of GAPDH of non-stimulated NHKÞ
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